Endpoint | Clois Na | Clois 30B | I-CloisNa | I-Clois30B | CS |
---|---|---|---|---|---|
Crystal structure | Montmorillonite | Montmorillonite | Amorphous quartz | Crystalline quartz | Crystalline quartz |
Mean particle size in RPMI (µm) | 0.304 | 1.064 | 2.302 | 2.104 | 0.786 |
Cellular uptake | +++; endosome | ++; endosome | +; endosome | +; endosome | ND |
w LPS | |||||
WST-1 viabilitya |  > 20 | 4.11 |  > 20 |  > 20 |  > 20 |
Live cell counta | 6.82 | 2.36 | 11.06 | 7.56 | 11.06 |
LDH cytotoxicity (%) | n/a | n/a | n/a | n/a | n/a |
Cathepsin B | 1.1 | 2.47 | 1.05 | 1.17 | 1.05 |
Caspase I | 1.60 | − 1.05 | 1.14 | 1.49 | − 1.11 |
Late apoptosis | 1.97 | 1.19 | 1.07 | 1.23 | − 1.41 |
IL-1β | 5.80 | 2.67 | 1.07 | − 1.04 | − 1.33 |
Gasdermin D cleavage (%) | 13.00 | 32.11 | 4.62 | 4.93 | 2.89 |
Inflammatory profile | IL-1β, TH1/TH2/TH17 | IL-1β, TH1/TH2/TH17 | Minimal | IL-1ra | IL-1ra |
w/o LPS | |||||
WST-1 viabilitya | 11.13 | 5.41 |  > 20 |  > 20 |  > 20 |
Live cell counta | 15.32 | 2.91 |  > 20 |  > 20 |  > 20 |
LDH cytotoxicity (%) | 14.5 | 74.6 | 22.5 | 16.4 | 13.6 |
IL-1α | 1.14 | 1.97 | 1.06 | 1.16 | 1.24 |
ATP | 3.19 | 6.2 | 2.56 | − 6.0 | 1.46 |
MMP | -1.23 | − 1.02 | − 1.02 | 1.01 | 1.05 |
Reactive oxygen species | − 1.39 | − 1.06 | − 1.18 | − 1.12 | − 1.01 |
Inflammatory profile | TH1/TH2/TH17 | TH1/TH2/TH17 | TH1/TH2/TH17 | MIP-1β, TNFα, IL-2, Eotaxin, FGFβ | MIP-1β |